Breast Cancer

Breast cancer is one of the most common malignancies affecting women worldwide, with diverse molecular subtypes influencing prognosis and treatment strategies. This session will explore advances in early detection, risk assessment, and personalized therapeutic approaches, including targeted therapy and immunotherapy. Emphasis will be placed on translational research, biomarker development, and emerging treatment modalities. The goal is to improve survival outcomes while enhancing quality of life for patients.